Tech Investment News- Another Strong Exit for HealthEdge Investment Partners with Sale of The Columbus Organization to CareSource - PRNewswire November 30, 2021Another Strong Exit for HealthEdge Investment Partners with Sale of The Columbus Organization to CareSource PRNewswire
- General Fusion closing oversubscribed $130 million transitional financing round - GlobeNewswire November 30, 2021General Fusion closing oversubscribed $130 million transitional financing round GlobeNewswire
- Prospect Park Capital Announces Proposed New Investment - GlobeNewswire November 30, 2021Prospect Park Capital Announces Proposed New Investment GlobeNewswire
- 29/2021・Trifork completes strategic review of Dawn Health - GlobeNewswire November 30, 202129/2021・Trifork completes strategic review of Dawn Health GlobeNewswire
- Report Shows Key Innovations to Face New Realities Within - GlobeNewswire November 30, 2021Report Shows Key Innovations to Face New Realities Within GlobeNewswire
- Another Strong Exit for HealthEdge Investment Partners with Sale of The Columbus Organization to CareSource - PRNewswire November 30, 2021
Tag Archives: Advanced Cell Technology Inc.
New Stem Cell Therapy Trial Approved
Another human embryotic stem cell therapy has been approved for clinical trials. Advanced Cell Technology Inc. announced that the Food and Drug Administration has approved the Phase I/II trial of retinal cells for Stargardt’s Macular Dystrophy patients. This condition is … Continue reading
Posted in Technology
Tagged Advanced Cell Technology Inc., retinal pigment epithelium, Robert Lanza, Stargardt’s Macular Dystrophy
Comments Off on New Stem Cell Therapy Trial Approved